Postsurgical Keytruda Boosts Survival in Clear Cell Renal Cell Carcinoma

Patients with clear cell renal cell carcinoma had improved overall survival when treated with adjuvant Keytruda compared to placebo.

Related Keywords

Boston ,Massachusetts ,United States ,Dana Farber Cancer Institute ,Nancy Kohlberg ,Toni Choueiri ,Kidney Cancer Program ,Lank Center ,Harvard Medical School ,Genitourinary Oncology ,Nancy Kohlberg Chair ,Enrollment Criteria ,Data Remains Consistent ,That Previously ,Genitourinary Cancers Symposium ,Kidney Cancer ,